Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporatedverified

CORT

Price:

$84.66

Market Cap:

$8.91B

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advance...[Read more]

Industry

Biotechnology

IPO Date

2004-04-14

Stock Exchange

NASDAQ

Ticker

CORT

The PE Ratio as of December 2025 (TTM) for Corcept Therapeutics Incorporated (CORT) is 97.31

According to Corcept Therapeutics Incorporated’s latest financial reports and current stock price. The company's current PE Ratio is 97.31. This represents a change of 9.65% compared to the average of 88.74 of the last 4 quarters.

Corcept Therapeutics Incorporated (CORT) Historical PE Ratio (quarterly & annually)

How has CORT PE Ratio performed in the past?

The mean historical PE Ratio of Corcept Therapeutics Incorporated over the last ten years is 20.76. The current 97.31 PE Ratio has changed 46.78% with respect to the historical average. Over the past ten years (40 quarters), CORT's PE Ratio was at its highest in in the June 2016 quarter at 153.73. The PE Ratio was at its lowest in in the March 2016 quarter at -6752.81.

Quarterly (TTM)
Annual

Average

20.76

Median

21.83

Minimum

-83.00

Maximum

98.61

Corcept Therapeutics Incorporated (CORT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Corcept Therapeutics Incorporated PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 759.85%

Maximum Annual PE Ratio = 98.61

Minimum Annual Increase = -218.81%

Minimum Annual PE Ratio = -83.00

Quarterly (TTM)
Annual
YearPE RatioChange
202437.2317.47%
202331.6948.19%
202221.395.07%
202120.35-28.54%
202028.4893.86%
201914.69-34.02%
201822.2740.23%
201715.88-83.90%
201698.61-218.81%
2015-83.00759.85%

Corcept Therapeutics Incorporated (CORT) Average PE Ratio

How has CORT PE Ratio performed in the past?

The current PE Ratio of Corcept Therapeutics Incorporated (CORT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

30.10

5-year avg

27.83

10-year avg

20.76

Corcept Therapeutics Incorporated (CORT) PE Ratio vs. Peers

How is CORT’s PE Ratio compared to its peers?

Corcept Therapeutics Incorporated’s PE Ratio is greater than Halozyme Therapeutics, Inc. (12.39), greater than Abivax S.A. (-30.21), greater than Rhythm Pharmaceuticals, Inc. (-35.36), greater than Merus N.V. (-20.81), greater than Cytokinetics, Incorporated (-10.62), greater than Jazz Pharmaceuticals plc (-27.49), greater than Caris Life Sciences, Inc. (-36.95), greater than Axsome Therapeutics, Inc. (-32.26), greater than Nuvalent, Inc. (-20.21), greater than Avidity Biosciences, Inc. (-20.35),

Build a custom stock screener for Corcept Therapeutics Incorporated (CORT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corcept Therapeutics Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corcept Therapeutics Incorporated (CORT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corcept Therapeutics Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Corcept Therapeutics Incorporated's PE Ratio?

How is the PE Ratio calculated for Corcept Therapeutics Incorporated (CORT)?

What is the highest PE Ratio for Corcept Therapeutics Incorporated (CORT)?

What is the 3-year average PE Ratio for Corcept Therapeutics Incorporated (CORT)?

What is the 5-year average PE Ratio for Corcept Therapeutics Incorporated (CORT)?

How does the current PE Ratio for Corcept Therapeutics Incorporated (CORT) compare to its historical average?